Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Hair changes and a high occipital hairline may help diagnose Trichorhinophalangeal Syndrome.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

The ABHRS held a test in Capri, Italy.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Habit reversal training effectively treats hair-pulling disorder in both adults and children.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

Proper management of GER in children is crucial for effective treatment and referrals.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Triangular temporal alopecia is a benign hair loss pattern best diagnosed with dermoscopy, with limited treatment options like surgery and hair transplantation.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

A 16-year-old girl with a hair-eating disorder needed surgery to remove a hairball from her stomach and small bowel.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Non-blinded assessors tend to overestimate effects in trials by about 29%.